NEVRO CORP - NOTE 1.750% 6/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q2 2021

Type / Class
Debt / NOTE 1.750% 6/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NEVRO CORP - NOTE 1.750% 6/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2021 Q2 $0 $0 -$252,147,000 0
2021 Q1 $176,398,000 $256,761,176 -$13,010,680 145.59% 12
2020 Q4 $177,722,000 $320,100,328 +$4,530,608 180.12% 11
2020 Q3 $176,751,000 $264,333,232 +$1,177,535 149.82% 12
2020 Q2 $176,956,000 $240,484,528 +$436,608 134.86% 11
2020 Q1 $176,549,000 $205,992,244 +$41,367 118.49% 11
2019 Q4 $173,737,000 $232,636,000 +$3,584,449 134.83% 12
2019 Q3 $176,188,000 $200,181,000 +$2,547,214 113.75% 12
2019 Q2 $174,247,994 $181,408,000 -$3,030,295 103.63% 12
2019 Q1 $178,204,000 $180,024,121 +$4,538,369 100.94% 15
2018 Q4 $174,930,000 $162,000,000 -$3,157,754 93.0% 13
2018 Q3 $177,542,000 $176,414,000 -$1,431,952 99.45% 14
2018 Q2 $172,814,011 $187,852,012 -$2,854,502 108.7% 26
2018 Q1 $175,399,004 $201,017,005 +$3,366,807 114.99% 21
2017 Q4 $172,329,640 $180,436,000 -$6,319,053 104.46% 20
2017 Q3 $172,327,648 $205,519,000 -$1,971,331 119.05% 21
2017 Q2 $175,663,640 $188,796,000 -$5,516,734 107.06% 22
2017 Q1 $178,572,004 $216,989,004 +$5,260,565 121.35% 21
2016 Q4 $176,620,150 $189,004,000 -$1,432,749 106.67% 25
2016 Q3 $173,990,006 $226,067,008 +$13,872,172 130.19% 21
2016 Q2 $164,740,000 $173,475,000 +$173,475,000 105.39% 24